(Q34481664)

2 August 2017

1 reference

title

Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections (English)

1 reference

invasive fungal infections

2 August 2017

1 reference

1 reference

A H Groll

1

1 reference

PubMed ID

11772269

2 August 2017

T J Walsh

series ordinal

2

1 reference

PubMed ID

11772269

2 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

1 reference

2 August 2017

10

1 reference

2 August 2017

8

1 reference

2 August 2017

1545-1558

1 reference

Antibiotics that inhibit fungal cell wall development

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

Aerosolized L-693,989 for Pneumocystis carinii prophylaxis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.8.1545

10.1517/13543784.10.8.1545

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11772269